Peter Attia· MD
because we're prioritizing what the overall risk to that human is
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
because we're prioritizing what the overall risk to that human is
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
very often um a Statin or um a lipid lowering compound results in a tiny elevation in an aminot transferase and when we're looking at net net cardiovascular risk we give blessings in the same way that we give blessings to chemotherapy induced liver injury um because we're prioritizing what the overall risk to that human is